Alternative lengthening of telomeres and ATRX/DAXX loss can reliably be detected in fine needle aspirates of pancreatic neuroendocrine tumors

Lignende værker

• Alternative lengthening of telomeres is not synonymous with mutations in ATRX/DAXX
  af: de Nonneville, Alexandre, et al.
  Udgivet: (2021)
• Formal reply to “Alternative lengthening of telomeres is not synonymous with mutations in ATRX/DAXX”
  af: Feuerbach, Lars
  Udgivet: (2021)
• Altered Telomeres in Tumors with ATRX and DAXX Mutations
  af: Heaphy, Christopher M., et al.
  Udgivet: (2011)
• Loss of ATRX or DAXX expression and concomitant acquisition of the alternative lengthening of telomeres phenotype are late events in a small subset of MEN-1 syndrome pancreatic neuroendocrine tumors
  af: de Wilde, Roeland F, et al.
  Udgivet: (2012)
• Alternative Lengthening of Telomeres and Loss of DAXX/ATRX Expression Predicts Metastatic Disease and Poor Survival in Patients with Pancreatic Neuroendocrine Tumors
  af: Singhi, Aatur D., et al.
  Udgivet: (2016)